An alliance with Rona Therapeutics adds to a particularly active stretch for Roche and makes the company the latest to bet on ...
An early data check showed the shot didn’t delay tumor progression in a form of head and neck cancer, though BioNTech is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results